Renal conditions

Summaries

Pregnant woman taking medication

UKKA pregnancy and renal disease guideline

2022-07-28T08:26:00+01:00By UK Kidney Association

Covering the care of women with CKD who are planning a pregnancy, pregnant, or in the postpartum period

kite_rin yoga exercise

Exercise and lifestyle in CKD guideline

2022-04-25T15:11:00+01:00By Baker L, March D, Wilkinson T et al

New summary covering recommendations for exercise and lifestyle for people with chronic kidney disease

Davizro Photography kidneys ipad

KDIGO management of glomerular diseases part 3 of 3

2022-03-22T14:22:00+00:00By Kidney Disease: Improving Global Outcomes

Covering the management of glomerular diseases in people of all ages

kidney_AS

KDIGO management of glomerular diseases part 2 of 3

2022-03-22T14:21:00+00:00By Kidney Disease: Improving Global Outcomes

Covering the management of glomerular diseases in people of all ages

Rasi kidney disease glomerular renal

KDIGO general management of glomerular diseases guideline

2022-03-22T11:22:00+00:00By Kidney Disease: Improving Global Outcomes

Covering the management of glomerular diseases in people of all ages

Educational resources

22-BM-330474 Index image

Anticoagulation management for elderly patients with NVAF, CKD and other comorbidities

Developed and funded by the Bristol Myers Squibb/Pfizer Alliance

This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting

Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com  or 0800 731 1736 (UK).

432-GB-2200204  May 2022